Qsymia (phentermine and topiramate)

**Product type:** Human Prescription Drug

**Active ingredient:** PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

**Strength:** 15; 92 mg/1; mg/1

**Dosage form:** Capsule, Extended Release

**Route:** Oral

**Labeler:** Vivus LLC

**Marketing category:** NDA (NDA022580)

**Pharmacologic class:** Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]

**DEA schedule:** CIV